BNP Paribas Financial Markets
VTGN icon

BNP Paribas Financial Markets’s VistaGen Therapeutics VTGN Stock Holding History

BNP Paribas Financial Markets’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Sell
6
-7
-54% -$4 ﹤0.01% 5897
2026
Q1 		$7 Hold
13
– – ﹤0.01% 5776
2025
Q4 		$9 Sell
13
-43
-77% -$155 ﹤0.01% 5697
2025
Q3 		$199 Sell
56
-422
-88% -$1.26K ﹤0.01% 5393
2025
Q2 		$956 Buy
478
+7
+1% +$16 ﹤0.01% 5153
2025
Q1 		$1.18K Sell
471
-2
-0.4% -$6 ﹤0.01% 5048
2024
Q4 		$1.4K Buy
+473
New +$1.33K ﹤0.01% 5048
2023
Q2 		– Sell
-3,207
Closed -$12K – 4035
2023
Q1 		$12K Buy
3,207
+1,876
+141% +$9.84K ﹤0.01% 3544
2022
Q4 		$4.11K Sell
1,331
-978
-42% -$3.68K ﹤0.01% 3677
2022
Q3 		$10.5K Buy
2,309
+839
+57% +$8.32K ﹤0.01% 4179
2022
Q2 		$38.8K Buy
1,470
+902
+159% +$31.8K ﹤0.01% 3610
2022
Q1 		$21.1K Sell
568
-817
-59% -$35.6K ﹤0.01% 3716
2021
Q4 		$81K Buy
1,385
+218
+19% +$14.2K ﹤0.01% 3653
2021
Q3 		$95.9K Buy
1,167
+921
+374% +$80K ﹤0.01% 3286
2021
Q2 		$23.2K Buy
+246
New +$18.2K ﹤0.01% 3496

Other funds holding VTGN

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CWS
Confluence Wealth Services Mcmurray, Pennsylvania $3.5B AUM 22.08% 1-Year Est. Return

BNP Paribas Financial Markets's VTGN Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its VistaGen Therapeutics (VTGN) stake by 54% in Q2 2026, selling an estimated $4 and leaving 6 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #5897.

BNP Paribas Financial Markets first reported a position in VTGN in Q2 2021 and has held it in 15 quarters since. The position peaked at $95.9K in Q3 2021. 26 funds tracked by Wall St. Rank hold VTGN as of Q2 2026.

  • BNP Paribas Financial Markets held 6 shares of VistaGen Therapeutics worth $1 as of Q2 2026.
  • BNP Paribas Financial Markets sold 7 VistaGen Therapeutics shares in Q2 2026, an estimated $4.
  • VistaGen Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5897 holding.
  • BNP Paribas Financial Markets first reported a position in VistaGen Therapeutics in Q2 2021 and has held it in 15 quarters since.
  • BNP Paribas Financial Markets's VistaGen Therapeutics position peaked at $95.9K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.